Following False-Positive Results, Patients More Likely to Have Future Cancer Screenings
The researchers found that the choice to undergo future screenings appeared to be influenced by previous false-positive results for both men and women.
The researchers found that the choice to undergo future screenings appeared to be influenced by previous false-positive results for both men and women.
A review of the literature on follow-up after positive screening results led researchers to a consensus opinion on timing of diagnostic tests for 4 cancers: breast, cervical, colorectal, and lung.
A logistic regression analysis determined the effect receiving a false-positive result had on future participation in cancer screenings.
Researchers conducted a case-control study to determine whether colonoscopy is associated with decreased CRC mortality in veterans and whether its effect differs by anatomical location of CRC.
A study using a cohort of women from Kaiser Permanente Washington evaluated the accuracy of risk assessment models for breast cancer that included classic risk factors with and without breast density as an additional factor during more than 10 years of follow-up.
Advances in breast imaging such as DBT offer better, clearer images of breast tissue that can identify even low-grade DCIS tumors. But will more sensitive imaging lead to improved outcomes or increased overtreatment?
The panel assembled and updated the above guidelines and recommendations regarding lung cancer screening and low-dose CT screening programs.
Fifty-three percent of intervention participants used app to self-order a colorectal screening test.
An USPSTF updated recommendation statement for ovarian cancer screening recommends against screening for women who are asymptomatic and do not have high-risk hereditary cancer syndrome.
An analysis of SEER data sought to examine the appropriateness of age- and race-specific breast cancer screening recommendations for white vs nonwhite women in the United States.